Furosemide: Difference between revisions

No edit summary
No edit summary
Line 7: Line 7:


==Adult Dosing==
==Adult Dosing==
''40mg [[furosemide]] = 20mg [[torsemide]] = 1mg [[bumetanide]]''
*[[Fluid overload]]: Typically 40 mg IV or  normal PO dosage IV
*[[Fluid overload]]: Typically 40 mg IV or  normal PO dosage IV
*[[hypertension]]: 10-40mg PO QDAY-BID, max 600mg/day
*[[hypertension]]: 10-40mg PO QDAY-BID, max 600mg/day

Revision as of 16:33, 22 December 2016

General

  • Type: Diuretic
  • Dosage Forms:20, 40, 80
  • Common Trade Names: Lasix
  • Approximately 50% bioavailability, so converting from oral to IV dose doubles oral dose[1]
  • Furosemide absorption may be reduced in decompensated CHF[2]

Adult Dosing

40mg furosemide = 20mg torsemide = 1mg bumetanide

Pediatric Dosing

Special Populations

  • Pregnancy Rating:C
  • Lactation: safety unknown
  • Renal Dosing
    • Adult: no adjustment, contraindicated in anuria
    • Pediatric: no adjustment, contraindicated in anuria
  • Hepatic Dosing
    • Adult: not defined
    • Pediatric: not defined

Contraindications

  • Allergy to class/drug
  • anuria
  • electrolyte imbalances

Adverse Reactions

Serious

  • hypokalemia
  • metabolic alkalosis
  • hypovolemia
  • ototoxicity
  • hemolytic anemia
  • vasculitis
  • steven-johnson syndrome
  • pancreatitis
  • eosinophilia

Common

  • urinary frequency
  • dizziness
  • nausea/vomiting
  • weakness
  • muscle cramping
  • hypokalemia
  • hypomagnesemia
  • blurred vision
  • diarrhea
  • hyperglycemia
  • hyperuricemia
  • tinnitus

Pharmacology

  • Half-life: 30-60 min
  • Metabolism: liver minimally
  • Excretion: urine
  • Mechanism of Action: inhibits loop of henle and proximal and distal convoluted tubule sodium and chloride resorption

See Also

References

  1. Asare K. Management of Loop Diuretic Resistance in the Intensive Care Unit. Am J Health Syst Pharm. 2009;66(18):1635-1640.
  2. Vasko MR, Brown-Cartwright D, Knochel JP et al. Furosemide absorption is altered in decompensated congestive heart failure. Ann Intern Med. 1985; 102: 314–8.